Datopotamab deruxtecan in locally advanced/metastatic urothelial cancer: Preliminary results from the phase 1 TROPION-PanTumor01 study.Aaron Lisberg, Takahiro Kogawa, Takahiro Kojima et al.|Journal of Clinical Oncology|2024Cited by 15
Datopotamab deruxtecan (Dato-DXd) in locally advanced/metastatic urothelial cancer: Updated results from the phase 1 TROPIONPanTumor01 study.Funda Meric‐Bernstam, Takahiro Kojima, Omar Alhalabi et al.|Journal of Clinical Oncology|2025Cited by 15